Patients as CEOs of Their Own Health – The Future Explained

Oncology of the future [Antonio Buzaid, oncologist] – Futuro Talks #97

Endocrinology in the Era of New Obesity Treatments - Thinking About the Future #20

The Challenge of Turning Research Into Innovation in Brazil

The Challenges of Chronic Kidney Disease – Talks Online

The Creation of Mexico's SUS - Future Explained

The Future of the Brazilian Pharmaceutical Industry

Pharmaceutical Sovereignty in Brazil [Norberto Prestes, President of Abiquifi] – Futuro Talks #96

How to make advanced therapies accessible to patients?

The History and Next Steps for Hemobrás – Futuro Explica

Social participation, Conitec, and access

Participação social nas decisões de saúde [Catherine Moura, CEO da Abrale] - Futuro Talks #95

A aposta que mudou a trajetória da MV

Innovation and Network Strategy [Gustavo Pinto, Director at Rede Américas] – Futuro Talks Special...

As emendas parlamentares na saúde – Futuro Explica

ASCO 2026: Oncology Highlights - Thinking About the Future

What will the digital health of the future look like?

Integração de dados e eficiência na saúde [Paulo Magnus, CEO da MV] – Futuro Talks #94

The boom in adulterated LPG in Brazil

The Future of Diagnostic Medicine [Marcos Queiroz, Director at Einstein] – Futuro Talks Special E...

PDPs: Brazil's bet on producing its own medicine - Futuro Explica

GLP-1 in addition to weight loss

A revolução dos medicamentos GLP-1 [Andressa Heimbecher Soares, endocrinologista] – Futuro Talks #93

Anvisa, pesquisa clínica e o desafio do acesso

Theranostics and the future of radiology [Clarissa Mathias, oncologist] – Futuro Talks Special Ed...

SXSW 2026 and Reflections on Technology – Future Explained

Does a single agency solve access to healthcare?

IBDs: Challenges and Trends - Future Explains Special Edition

From innovation to therapy access [Christiano Silva, BMS Brazil Manager] – Futuro Talks #92

O espaço dos biossimilares com a queda de patentes

The Future of AI in Radiology [Giovanni Cerri, President of the InRad and ICOS Council] – Future ...

Digital coaching for health: a distant or near dream? – Future Explains

A New Era for Anvisa [Leandro Safatle, CEO of Anvisa] - Futuro Talks #91

Access depends on data integration.

Real-world data: the revolution that is changing medicine – Future Explained

Access to healthcare: why do patients still wait so long in Brazil?

Pharmaceutical industry and access [Andrea Sambati, CEO Boehringer Ingelheim Brazil] Future Talks...

Screen use and obesity are challenges for early childhood - Thinking about the Future

O que está por trás do aumento dos planos

Interoperability in healthcare: new projects with transformative potential – Future Explains

Why supplemental health insurance isn't growing

Supplementary healthcare undergoing transformation [Sami Foguel, CEO of Porto Saúde] – Futuro Tal...

Qualidade de vida no fim da vida

BRCA: the genetic test that could save lives – Future Explains

Cardiology in the era of precision medicine - Thinking about the Future

A associação Eu Decido

Decisões de vida do paciente [Luciana Dadalto, fundadora da Eu Decido] - Futuro Talks #88

A importância dos protocolos de câncer

Medical education in Brazil - Future Explains

A política nacional do câncer

Os desafios do câncer no Brasil [Angélica Nogueira, presidente de honra da SBOC] – Futuro Talks #87

Neurology is experiencing a moment of transition - Thinking about the Future

Gestão eficiente e evidência técnica

HLTH 2025: o que Las Vegas revelou sobre o futuro da saúde – Futuro Explica

Terapias domiciliares em doenças raras [Rafael Freixo e Antoine Daher] – Futuro Talks Ed.Especial

Investment in comprehensive medical education

Evolução da gestão hospitalar [Fernando Ganem, diretor-geral do Sírio-Libanês] – Futuro Talks #86

Os custos das terapias oncológicas

How Anvisa Works - Future Explains

A importância do diálogo no setor